EUVIMEDEUVIMED entdecken
Crossref

Combined WNT-activated deep-penetrating/plexiform melanocytoma: insights into clinicopathological and molecular characterization

Paola Castillo iD, Natalia Castrejon, Marta Marginet, Daniela Massi, Francesc Alamon, Cristina Teixido, Carla Montironi, Adriana Garcia-Herrera, Raquel Albero-Gonzalez, Jessica Matas, Susana Puig iD, Llucia Alos iD

Clinical and Experimental Dermatology · 2024

DOI: 10.1093/ced/llad405 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Experimental Dermatology, 2024. Verfasst von Paola Castillo und 11 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Pathology. Hauptthemen laut MEDLINE: Melanoma, Nevus, Epithelioid and Spindle Cell, Skin Neoplasms, Succinimides. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

A combined deep-penetrating tumour redefined as WNT-activated deep-penetrating/plexiform melanocytoma (DPM), may pose challenging clinical and histological diagnoses.

Objectives

To review the clinicopathological characteristics of combined DPMs and characterize the molecular profile of atypical and malignant forms.

Methods

The study included 51 patients with combined DPMs diagnosed at the Hospital Clinic of Barcelona and the University of Florence between 2012 and 2020. Clinical data, dermoscopy images (when available) and histological characteristics were reviewed. Immunohistochemistry for β-catenin, LEF1, HMB45, Ki67, p16 and PRAME (preferentially expressed antigen in melanoma) was performed. Atypical forms underwent next-generation sequencing (NGS) panel analysis, including driver genes implicated in DPMs, TERT-promoter (p) mutations and the investigation of the 9p21 locus via fluorescence in situ hybridization.

Results

Among the 51 patients (32 females and 19 males, age range 4–74 years), 68% with available clinical data (15/22) were initially suspected of having melanoma. Except for one patient, complete excision resulted in no recurrences or metastases. One patient who had an incompletely excised combined DPM developed a lymph node melanoma metastasis 10 years later. In the 51 patients, 10 samples (20%) showed atypical histological features; 7 (14%) exhibited a significant loss of p16 expression; and 2 (4%) showed a high-proliferative index (Ki67 over 5%). NGS analysis in 11 patients revealed a double mutation BRAFV600E and exon 3 CTNNB1; no TERTp mutations were detected.

Conclusions

Clinical suspicion of melanoma is common in combined DPMs, but malignant progression is infrequent in tumours lacking high-grade atypia or proliferation. These findings are congruent with the consideration of these lesions as intermediate-grade tumours or melanocytomas.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaNevus, Epithelioid and Spindle CellSkin NeoplasmsSuccinimidesMaleFemaleHumansChild, PreschoolChildAdolescentYoung AdultAdultMiddle AgedAgedKi-67 AntigenIn Situ Hybridization, FluorescenceLymphatic MetastasisMutationAntigens, Neoplasm

Substanzen

3-(3,5-dichlorophenyl)-1-methyl-2,5-pyrrolidinedioneKi-67 AntigenPRAME protein, humanAntigens, NeoplasmSuccinimides

Autor:innen und Institutionen

  • Departments of Pathology.
  • University of Barcelona. Barcelona, Spain.
  • August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.
  • Section of Anatomical Pathology, Department of Health Sciences, University of Florence. Florence, Italy.
  • European Organisation for Research and Treatment of Cancer (EORTC), Melanoma Group.
  • Dermatology.

ORCID-Profile: Paola Castillo, Susana Puig, Llucia Alos

Zitieren

APA

Castillo, P., Castrejon, N., Marginet, M., Massi, D., Alamon, F., Teixido, C., Montironi, C., Garcia-Herrera, A., Albero-Gonzalez, R., Matas, J., Puig, S., & Alos, L. (2024). Combined WNT-activated deep-penetrating/plexiform melanocytoma: insights into clinicopathological and molecular characterization. Clinical and Experimental Dermatology. https://doi.org/10.1093/ced/llad405

Vancouver

Castillo P, Castrejon N, Marginet M, Massi D, Alamon F, Teixido C, et al. Combined WNT-activated deep-penetrating/plexiform melanocytoma: insights into clinicopathological and molecular characterization. Clinical and Experimental Dermatology. 2024. doi:10.1093/ced/llad405

BibTeX
@article{Castillo2024,
  author = {Castillo, Paola and Castrejon, Natalia and Marginet, Marta and Massi, Daniela and Alamon, Francesc and Teixido, Cristina and Montironi, Carla and Garcia-Herrera, Adriana and Albero-Gonzalez, Raquel and Matas, Jessica and Puig, Susana and Alos, Llucia},
  title = {Combined WNT-activated deep-penetrating/plexiform melanocytoma: insights into clinicopathological and molecular characterization},
  journal = {Clinical and Experimental Dermatology},
  year = {2024},
  doi = {10.1093/ced/llad405}
}
Kostenlos starten →